Abstract:Autophagy, the bulk intracellular degradation of cytoplasmic constituents, can be a pro-survival or a pro-death mechanism depending on the context. A recent study showed that autophagy was activated in the phase of early brain injury following subarachnoid hemorrhage (SAH). However, whether autophagy activation after SAH is protective or harmful is still elusive. This study was undertaken to determine the potential role of autophagy pathway activation in early brain injury following SAH. The rats were pretreated with intracerebral ventricular infusion of either the autophagy inducer rapamycin (RAP) or inhibitor 3-methyladenine (3-MA) before SAH onset. The results from electron microscopic examinations showed that RAP administration caused the formation of autophagosomal vacuoles, and 3-MA induced neuronal apoptosis. RAP treatment significantly increased the expression of autophagic proteins Atg5 and Beclin 1, the ratio of microtubule-associated protein 1 light chain 3 (LC3)-II to LC3-I and reduced caspase-3 activity, the number of terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL)-positive cells, brain edema and neurological deficits after SAH. Conversely, 3-MA treatment exacerbated early brain injury. RAP treatment significantly increased the expression of the autophagic proteins Atg5 and Beclin 1, the ratio of LC3-II to LC3-I and reduced caspase-3 activity, the number of TUNEL-positive cells, brain edema and neurological deficits after SAH. Conversely, 3-MA treatment reversed these changes and exacerbated early brain injury. To further clarify the mechanism of autophagy protection, we investigated the expression levels of key apoptosis-related molecules. The results showed that RAP administration decreased Bax translocation to the mitochondria and downstream cytochrome c release from the mitochondria to the cytosol. Taken together, our study indicates that activation of autophagic pathways reduces early brain injury after SAH. This neuroprotective effect is likely exerted by anti-apoptotic mechanisms.

[Autophagy regulates multiple organ injury in obstructive sleep apnea and its related mechanisms]

The role of neuronal autophagy in hypoxic-ischemic brain injiny

Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

Progresses in Clinical and Basic Research of Myocardial Injury Caused by Obstructive Sleep Apnea

Autophagy impairment in patients with obstructive sleep apnea modulates intermittent hypoxia-induced oxidative stress and cell apoptosis via hypermethylation of the ATG5 gene promoter region

Is brain damage really involved in the pathogenesis of obstructive sleep apnea?

Association Between Obstructive Sleep Apnea and Cardiovascular Diseases.

Obstructive sleep apnea affects cognition: dual effects of intermittent hypoxia on neurons

Autophagy Activation is Associated with Neuroprotection Against Apoptosis Via a Mitochondrial Pathway in a Rat Model of Subarachnoid Hemorrhage

Structural and Functional Brain Alterations in Obstructive Sleep Apnea: a Multimodal Meta-Analysis.

Relationships Between Obstructive Sleep Apnea Syndrome and Damage of the Target Organs in Hypertension

Obstructive Sleep Apnea-Hypopnea and Cardiovascular Diseases in Adults

Chronic Effects of Obstructive Sleep Apnea on Dog Left Ventricular Systolic Performance

[Progress in obstructive sleep apnea and atherosclerosis]

Advances in Multimodal Echocardiographic Evaluation of Ischemic Cardiomyopathy due to Obstructive Sleep Apnea Syndrome

Sleep apnea-hypopnea syndrome caused brain injury and its mechanism

Obstructive sleep apnoea and cardiovascular complications: perception versus knowledge.

Cyclic Intermittent Hypoxia Induces Apoptosis Through Upregulation of LncRNA GAS5 Expression in Cardiomyocyte

Disease characteristics and neuropathological changes associated with cognitive dysfunction in obstructive sleep apnea

Sleep apnea and autonomic dysfunction in patients with dementia

Obstructive Sleep Apnea Syndrome and Metabolic Diseases